← European Medicine Shortage Tracker · all medicines

Candesartan shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Candesartan currently has availability issues reported in 2 European registers: Spain, Italy.

Shortage  ATC — · also listed as: CANDESARTAN · data refreshed 9 September 2026

Key facts

As of 9 September 2026, 2 of the 9 tracked registers list current availability issues for Candesartan, covering 8 affected product presentations. The longest-running open report was filed in Spain on 2025-12-09 and has now been open for about 9 months. Where agencies state a cause, manufacturing problems lead with 3 of the 3 stated-cause reports. The furthest expected-resolution date currently on file is 2027-05-06; the earliest is 2026-11-30. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
CANDESARTAN SUN 32 mg COMPRIMIDOS EFG , 28 comprimidos
+ 4 more products
CANDESARTAN VIATRIS 16 MG COMPRIMIDOS EFG, 28 comprimidos
CANDESARTAN VIATRIS 32 MG COMPRIMIDOS EFG, 28 comprimidos
CANDESARTAN VIATRIS 4 MG COMPRIMIDOS EFG, 14 comprimidos
CANDESARTAN VIATRIS 8 MG COMPRIMIDOS EFG, 28 comprimidos
2025-12-092027-05-06Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇮🇹 ItalyShortage
CANDESARTAN PENSA
+ 2 more products
CANDESARTAN PENSA
CANDESARTAN TEVA ITALIA
2026-09-012026-12-31Problemi produttivi
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2025-12: 22026-01: 02026-02: 12026-03: 12026-04: 02026-05: 02026-06: 12026-07: 02026-08: 02026-09: 12025-122026-09

Full report history (8 register entries)

Every individual register entry for Candesartan in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITCANDESARTAN PENSAShortage2026-11-012026-12-31Problemi produttivi
🇮🇹 ITCANDESARTAN TEVA ITALIAShortage2026-10-152026-11-30Problemi produttivi
🇮🇹 ITCANDESARTAN PENSAShortage2026-09-012026-12-31Problemi produttivi
🇪🇸 ESCANDESARTAN VIATRIS 8 MG COMPRIMIDOS EFG, 28 comprimidosShortage2026-06-232027-03-22Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ESCANDESARTAN VIATRIS 32 MG COMPRIMIDOS EFG, 28 comprimidosShortage2026-03-152027-05-06Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ESCANDESARTAN VIATRIS 16 MG COMPRIMIDOS EFG, 28 comprimidosShortage2026-02-172027-05-06Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ESCANDESARTAN SUN 32 mg COMPRIMIDOS EFG , 28 comprimidosShortage2025-12-112027-01-30Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ESCANDESARTAN VIATRIS 4 MG COMPRIMIDOS EFG, 14 comprimidosShortage2025-12-092027-05-06Existen otros medicamentos con el mismo principio activo y m

Frequently asked

Is Candesartan currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Candesartan shortage expected to end?

Agency prognoses on file range from 2026-11-30 to 2027-05-06. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Candesartan?

8 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Candesartan availability data come from?

Directly from the official medicines-agency registers that list Candesartan: AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Candesartan — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/candesartan/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Candesartan availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/candesartan/">Candesartan shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Candesartan: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.